-
Mashup Score: 0
To prospectively examine the outcomes, toxicity and quality of life (QoL) of patients with post-cricoid and upper oesophagus (PCUE) cancers treated with an organ-preservation approach of (chemo)-radiotherapy using intensity-modulated image-guided radiotherapy (IM-IGRT).
Source: Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The impact of the social determinants on health are well documented, whereby the conditions in which people are ‘born, grow, work, live and age’ influence individual health status [1]. Marmot’s strategic review of health inequalities in 2010 ‘Fair Society Healthy Lives’ [2] was commissioned back in 2008 by the then Secretary of State for Health to propose an evidence-based strategy to address the…
Source: Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Radiation therapy is a complex process involving multiple professionals and steps from simulation to treatment planning to delivery, and these procedures are prone to error. Additionally, the imaging and treatment delivery equipment in radiotherapy is highly complex and interconnected and represents another risk point in the quality of care. Numerous quality assurance tasks are carried out to…
Source: Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation - 3 year(s) ago
Most randomised controlled trials (RCTs) in oncology are now funded by the pharmaceutical industry. We explore the extent to which RCT design, results and interpretation differ between industry-funded and non-industry-funded RCTs.
Source: Clinical OncologyCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 0Industry Funding of Oncology Randomised Controlled Trials: Implications for Design, Results and Interpretation - 3 year(s) ago
Most randomised controlled trials (RCTs) in oncology are now funded by the pharmaceutical industry. We explore the extent to which RCT design, results and interpretation differ between industry-funded and non-industry-funded RCTs.
Source: Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Should We be Offering Our Patients With Oligometastases Stereotactic Ablative Body Radiotherapy? - 3 year(s) ago
The oligometastatic state was first described in 1995 [1] and, yet, 26 years later we are still debating whether patients with oligometastases require different management and whether they can be cured of their malignancy. Nearly half a century ago surgical reports of excision of solitary liver metastases from colorectal cancer were published, with 40% 5-year survival rates [2,3]. Metastatectomy…
Source: Clinical OncologyCategories: Latest Headlines, Oncologists1Tweet-
Should We be Offering Our Patients With Oligometastases Stereotactic Ablative Body Radiotherapy? https://t.co/qm2f5fNmuk
-
-
Mashup Score: 0Curative-Intent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck in Sri Lanka: The Impact of Radiotherapy Technique on Survival - 3 year(s) ago
We conducted a retrospective analysis of patients with squamous cell carcinoma of the head and neck (SCCHN) treated with curative-intent radiotherapy at the National Cancer Institute of Sri Lanka to determine the impact of the treatment technique on disease-free survival (DFS).
Source: Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Instant Oncology: Z0011 - 3 year(s) ago
The author declares no conflict of interest.
Source: Clinical OncologyCategories: Latest Headlines, Oncologists1Tweet-
Dr. Wang throwing some red ! points (and shade) on Z0011; says "[H]as gone down in history as causing more controversy than it solved"(?) How long will we continue to "litigate" this trial. It's the blue/gold dress of breast oncology (esp to rad oncs). https://t.co/s0aHcuNj4S https://t.co/neuGuuingw
-
-
Mashup Score: 2Multicentre Investigation of Prognostic Factors Incorporating p16 and Tumour Infiltrating Lymphocytes for Anal Cancer After Chemoradiotherapy - 3 year(s) ago
Anal squamous cell carcinomas (ASCC) are strongly associated with human papillomaviruses. Standard of care is chemoradiotherapy at uniform doses with no treatment stratification. Immunohistochemical staining for p16INK4A (p16), a surrogate for human papillomaviruses, is prognostic for outcomes. We investigated this alongside clinical-pathological factors, including tumour infiltrating lymphocyte…
Source: Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6
In 2020, the World Health Organization launched a major initiative to eliminate cervical cancer globally. The initiative is built around the three key pillars of human papillomavirus (HPV) vaccination, cervical screening and treatment, with associated intervention targets for the year 2030. The ‘90-70-90’ targets specify that 90% of adolescent girls receive prophylactic HPV vaccination, 70% of…
Source: Clinical OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
April's Editor's choice #freeaccess article from Clinical Oncology: Post-cricoid and Upper Oesophagus Cancers Treated with Organ Preservation Using Intensity-modulated Image-guided Radiotherapy Online here https://t.co/bHXlJp7Ypr @RCRadiologists @ClinOncology